Smart medical devices market seen reaching $294.1 billion by 2035

Market Research Future projects the global smart medical devices market will grow from $96.88 billion in 2025 to $294.10 billion by 2035, driven by reimbursement changes, edge AI, and 5G-connected remote monitoring. The forecast points to faster adoption in hospitals, home care, and emerging markets as regulators and payers push care closer to patients.

Why it matters: - Smart medical devices are moving from optional upgrades to core care infrastructure as payers reward outcomes instead of volume. - The market's growth reflects a broader shift toward remote monitoring, earlier intervention, and more automated clinical decision-making. - The expansion could reshape device purchasing, care delivery, and reimbursement across hospitals and home-care settings.

What happened: - Market Research Future projected the global smart medical devices market will rise from USD 96.88 billion in 2025 to USD 294.10 billion by 2035. - The forecast implies an 11.74% compound annual growth rate from 2026 to 2035. - The market is projected to reach USD 108.25 billion in 2026. - The release framed value-based reimbursement policies, edge AI, on-device inference, and 5G-enabled remote patient monitoring as the main growth drivers.

The details: - Value-based reimbursement is pushing hospitals and payers to prioritize devices that help avoid readmissions and improve measurable outcomes. - The CMS Hospital Readmissions Reduction Program penalized more than 2,500 hospitals in FY 2024, reducing Medicare payments by an estimated USD 550 million. - Germany's DiGA fast-track pathway has led to more than 60 connected-device submissions since 2020. - The UK's NHS has committed GBP 2.1 billion to its digital-transformation roadmap through 2028. - Edge AI and on-device inference reduce latency from seconds to milliseconds and keep clinical data processing closer to the point of care. - Qualcomm's 2024-generation healthcare SoC cut inference power draw by 40% versus its predecessor. - Published research cited 15% to 25% reductions in adverse events using FDA-cleared algorithms in atrial fibrillation diagnosis, diabetic retinopathy screening, and sepsis early warning. - 5G connectivity is expanding remote patient monitoring beyond hospitals and into homes and rural settings. - South Korea allocated KRW 420 billion in 2024 to subsidize 5G-connected chronic-disease kits for rural communities. - The FCC's Connected Care Pilot Program provided USD 100 million to 85 health systems for cellular-enabled remote monitoring trials. - Diagnostic and monitoring devices were the largest product segment in 2025, with a 58.6% share. - Therapeutic devices were the fastest-growing product segment, with a forecast 14.2% CAGR through 2035. - Hospitals and clinics were the largest end-user segment in 2025, with a 48.9% share. - Home-care settings were the fastest-growing end-user segment, with a forecast 14.78% CAGR. - Bluetooth held the largest connectivity share in 2025 at 37.6%. - Cellular and 5G was the fastest-growing connectivity segment, with a projected 17.4% CAGR through 2035. - Offline distribution held 71.4% of the market in 2025. - Online distribution was the fastest-growing channel, with a projected 13.9% CAGR through 2035. - North America held about 46.0% of the market in 2025, making it the largest regional market. - Europe held about 27.5% of the market in 2025. - Asia-Pacific was the fastest-growing region, with a projected 16.24% CAGR through 2035. - South America's market was valued at USD 4.36 billion in 2025. - The Middle East and Africa market was valued at USD 3.87 billion in 2025.

Between the lines: - The forecast suggests the category is being pulled by policy and infrastructure, not just consumer demand. - Regulatory clarity, reimbursement incentives, and cheaper chipsets are making connected devices viable in more care settings. - The emphasis on software and analytics points to a shift from one-time hardware sales toward recurring revenue models. - The competitive field remains medium-concentrated, with the top five players holding an estimated 35% to 42% of revenue. - Medtronic, Abbott Laboratories, Philips Healthcare, and Johnson & Johnson MedTech were highlighted as key players with recent product and platform milestones.

What's next: - The release said AI-autonomous clinical decision support is expected to become central to smart-device management by 2030. - Closed-loop insulin delivery is presented as an early model for future feedback systems in cardiac pacing, ventilator management, and pain-pump titration. - Software and services are projected to account for more than 40% of smart-device OEM revenue by 2032, up from about 22% in 2025. - The EU's proposed Ecodesign for Sustainable Products Regulation could make durability and repairability a procurement factor by 2028. - Request a free sample or read the detailed report.